Patents Assigned to ImmunOnc, Inc.
  • Immunocapture assay for cancer procoagulant antibody complex in biological samples
    Patent number: 5601988
    Abstract: This invention provides a specific immunocapture ELISA for the quantitation of cancer procoagulant antibody complex (CPAC) in biological samples. In particular, this invention provides methods and techniques for specifically selecting and quantitatively measuring CPAC from a sample material using anti-CP antibodies followed by labeled anti-immunoglobulin antibodies. The amount of captured CPAC is then determined by measuring the amount of label in the captured CPAC.
    Type: Grant
    Filed: May 20, 1994
    Date of Patent: February 11, 1997
    Assignee: ImmunOnc, Inc.
    Inventor: Stuart G. Gordon